Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessPfizer’s green chemistry team turns 25
What began as a grassroots initiative has become embedded across Pfizer’s research and manufacturing operations, helping reshape processes from Viagra to Paxlovid
-
OpinionMessy megamergers
Rumoured merger between AstraZeneca and Bristol Myers Squibb has collapsed, and that’s probably a good thing
-
BusinessOral cholesterol-lowering peptide approved after a decade in development
Merck & Co’s Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis
-
PodcastThermo Fisher data manipulation & the shrinking chemical recycling industry
We discuss fabricated images in Thermo Fisher’s online catalogue. And, what barriers are preventing chemical plastic recycling from taking off?
-
OpinionTrump threatens generic drug tariffs
Plan aims to encourage domestic US supplies, but will it work?
-
BusinessJ&J proposes $5.5 billion settlement deal for talc cancer lawsuits
Deal would resolve 76,000 cases of women claiming talc caused ovarian cancer
-
BusinessIndia’s generic GLP-1 drugs are (mostly) booming
Manufacturing problems for some manufacturers have led to production pauses and recalled batches of diabetes and weight loss drugs
-
OpinionTrust is easily broken and hard to rebuild
Thermo Fisher needs to be open and honest about data manipulation to reassure researchers
-
BusinessThermo Fisher antibody data manipulation is a breach of trust, say researchers
Science sleuths say the problem is impacting research progress and Thermo’s response falls short
-
WebinarOne goal, three industries: retrosynthesis for pharma, agrochemicals and flavours & fragrances
Join us on 15 September as we explore the latest in AI-powered retrosynthetic software, evaluating its performance across three different industries
-
BusinessRegulators push Amgen to withdraw drug due to data manipulation
Questions raised over safety and efficacy of Tavneos (avacopan)
-
BusinessRewriting genetic medicine
Scribe Therapeutics will soon begin clinical trials for its epigenetic treatment to tackle ‘bad’ cholesterol
-
OpinionWhat kinds of reactions do you do most?
Variety may be the spice of life, but there’s space for the boring but effective
-
OpinionGSK agrees $10 billion deal for Nuvalent cancer drugs
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline
-
OpinionHow far will EU push for fairer trade with China?
Strengthening rules on pharmaceutical and chemical trade could protect critical industries
-
BusinessEU looks to boost protective trade policy against Chinese imports
Critical Medicines Act and rumoured chemicals rules aim to decrease China’s supply chain dominance
-
BusinessUK government promises £350 million support for the chemicals sector
Officials say funding will help industry build resilience, remain competitive and decarbonise
-
BusinessUS FDA commissioner Makary resigns amid chaos and questions
Marty Makary’s departure, amid reports that Trump planned to fire him, is the result of an ‘inherited crisis’ and ‘shifting FDA standards’, BIO says
-
OpinionIran war’s global impact keeps growing
Shortages of bitumen, cooking gas and jet fuel are pushing up prices and disrupting construction
-
ArticleAdvantages of monodisperse PEG in drug development
Precision matters: why monodisperse PEG is transforming drug development.